Cargando…
Design and Mechanism of Action of a New Prototype of Combi-Molecule “Programed” to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment
The clinical use of cytotoxic agents is plagued by systemic toxicity. We report a novel approach that seeks to design a “combi-molecule” to behave as an alkylating agent on its own and to undergo acid-catalyzed conversion to two bioactive species at a pH range akin to that of a tumor microenvironmen...
Autores principales: | Larroque-Lombard, Anne-Laure, Chatelut, Etienne, Delord, Jean-Pierre, Imbs, Diane-Charlotte, Rochaix, Philippe, Jean-Claude, Bertrand, Allal, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920489/ https://www.ncbi.nlm.nih.gov/pubmed/33669415 http://dx.doi.org/10.3390/ph14020160 |
Ejemplares similares
-
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
por: Rao, Suman, et al.
Publicado: (2021) -
Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem
Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept
of Type III Combi-Targeting
por: Rao, Suman, et al.
Publicado: (2015) -
Consultor Combi visual
Publicado: (1992) -
Consultor Combi visual
Publicado: (1988) -
Enciclopedia Combi visual
Publicado: (1976)